Literature DB >> 20231866

Why match? Investigating matched case-control study designs with causal effect estimation.

Sherri Rose1, Mark J van der Laan.   

Abstract

Matched case-control study designs are commonly implemented in the field of public health. While matching is intended to eliminate confounding, the main potential benefit of matching in case-control studies is a gain in efficiency. Methods for analyzing matched case-control studies have focused on utilizing conditional logistic regression models that provide conditional and not causal estimates of the odds ratio. This article investigates the use of case-control weighted targeted maximum likelihood estimation to obtain marginal causal effects in matched case-control study designs. We compare the use of case-control weighted targeted maximum likelihood estimation in matched and unmatched designs in an effort to explore which design yields the most information about the marginal causal effect. The procedures require knowledge of certain prevalence probabilities and were previously described by van der Laan (2008). In many practical situations where a causal effect is the parameter of interest, researchers may be better served using an unmatched design.

Entities:  

Mesh:

Year:  2009        PMID: 20231866      PMCID: PMC2827892          DOI: 10.2202/1557-4679.1127

Source DB:  PubMed          Journal:  Int J Biostat        ISSN: 1557-4679            Impact factor:   0.968


  17 in total

1.  Analysis of matched case-control data.

Authors:  Yin-Bun Cheung
Journal:  J Clin Epidemiol       Date:  2003-08       Impact factor: 6.437

Review 2.  Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case-control studies.

Authors:  Sander Greenland
Journal:  Am J Epidemiol       Date:  2004-08-15       Impact factor: 4.897

3.  Estimation based on case-control designs with known prevalence probability.

Authors:  Mark J van der Laan
Journal:  Int J Biostat       Date:  2008       Impact factor: 0.968

4.  Simple optimal weighting of cases and controls in case-control studies.

Authors:  Sherri Rose; Mark J van der Laan
Journal:  Int J Biostat       Date:  2008-09-29       Impact factor: 0.968

Review 5.  Matching.

Authors:  M C Costanza
Journal:  Prev Med       Date:  1995-09       Impact factor: 4.018

6.  A comparison of three approaches to estimate exposure-specific incidence rates from population-based case-control data.

Authors:  J Benichou; S Wacholder
Journal:  Stat Med       Date:  1994 Mar 15-Apr 15       Impact factor: 2.373

7.  Matching in epidemiologic studies: validity and efficiency considerations.

Authors:  L L Kupper; J M Karon; D G Kleinbaum; H Morgenstern; D K Lewis
Journal:  Biometrics       Date:  1981-06       Impact factor: 2.571

8.  Multivariate estimation of exposure-specific incidence from case-control studies.

Authors:  S Greenland
Journal:  J Chronic Dis       Date:  1981

9.  Estimation of multiple relative risk functions in matched case-control studies.

Authors:  N E Breslow; N E Day; K T Halvorsen; R L Prentice; C Sabai
Journal:  Am J Epidemiol       Date:  1978-10       Impact factor: 4.897

Review 10.  Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.

Authors:  Jan P Vandenbroucke; Erik von Elm; Douglas G Altman; Peter C Gøtzsche; Cynthia D Mulrow; Stuart J Pocock; Charles Poole; James J Schlesselman; Matthias Egger
Journal:  PLoS Med       Date:  2007-10-16       Impact factor: 11.069

View more
  78 in total

1.  Simple optimal weighting of cases and controls in case-control studies.

Authors:  Sherri Rose; Mark J van der Laan
Journal:  Int J Biostat       Date:  2008-09-29       Impact factor: 0.968

2.  Collaborative double robust targeted maximum likelihood estimation.

Authors:  Mark J van der Laan; Susan Gruber
Journal:  Int J Biostat       Date:  2010-05-17       Impact factor: 0.968

3.  A targeted maximum likelihood estimator for two-stage designs.

Authors:  Sherri Rose; Mark J van der Laan
Journal:  Int J Biostat       Date:  2011-03-11       Impact factor: 0.968

4.  Malaria epidemiology and comparative reliability of diagnostic tools in Bannu; an endemic malaria focus in south of Khyber Pakhtunkhwa, Pakistan.

Authors:  Fatima Jahan; Nazma Habib Khan; Sobia Wahid; Zaki Ullah; Aisha Kausar; Naheed Ali
Journal:  Pathog Glob Health       Date:  2019-03-21       Impact factor: 2.894

5.  ADAPTIVE MATCHING IN RANDOMIZED TRIALS AND OBSERVATIONAL STUDIES.

Authors:  Mark J van der Laan; Laura B Balzer; Maya L Petersen
Journal:  J Stat Res       Date:  2012-12-01

6.  Psychosocial Risk Factors and Other Than Honorable Military Discharge: Providing Healthcare to Previously Ineligible Veterans.

Authors:  Eric B Elbogen; H Ryan Wagner; Mira Brancu; Nathan A Kimbrel; Jennifer C Naylor; Cindy M Swinkels; John A Fairbank
Journal:  Mil Med       Date:  2018-09-01       Impact factor: 1.437

7.  Estimating the Effect of a Community-Based Intervention with Two Communities.

Authors:  Mark J van der Laan; Maya Petersen; Wenjing Zheng
Journal:  J Causal Inference       Date:  2013-05

8.  Does pre-operative chemoradiation for initially unresectable or borderline resectable pancreatic adenocarcinoma increase post-operative morbidity? A case-matched analysis.

Authors:  Raphael L C Araujo; Sébastien Gaujoux; Florence Huguet; Mithat Gonen; Michael I D'Angelica; Ronald P DeMatteo; Yuman Fong; T Peter Kingham; William R Jarnagin; Karyn A Goodman; Peter J Allen
Journal:  HPB (Oxford)       Date:  2013-01-10       Impact factor: 3.647

9.  Trajectory of Excess Medical Expenditures 10 Years Before and After Diabetes Diagnosis Among U.S. Adults Aged 25-64 Years, 2001-2013.

Authors:  Sundar S Shrestha; Ping Zhang; Israel A Hora; Edward W Gregg
Journal:  Diabetes Care       Date:  2018-11-19       Impact factor: 19.112

10.  Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor α.

Authors:  James N Ingle; Junmei Cairns; Vera J Suman; Lois E Shepherd; Peter A Fasching; Tanya L Hoskin; Ravinder J Singh; Zeruesenay Desta; Krishna R Kalari; Matthew J Ellis; Paul E Goss; Bingshu E Chen; Bernhard Volz; Poulami Barman; Erin E Carlson; Tufia Haddad; Matthew P Goetz; Barbara Goodnature; Matthew E Cuellar; Michael A Walters; Cristina Correia; Scott H Kaufmann; Richard M Weinshilboum; Liewei Wang
Journal:  Clin Cancer Res       Date:  2020-02-25       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.